RxDoctor Payments Data

Joshua Murphy, MD

Adult Reconstructive Orthopaedic Surgery · Cincinnati, OHNPI 1982866356

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (44.7%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by Smith+Nephew at 57.7% of the total. Reporting peaked in 2020 at $24,711 and has fallen 97.7% since, to $574 in 2025.

$48,706in general payments, 2019–2025

Across 62 payments — averaging $785.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$28K
  • Stryker$8K
  • Medical Device Business Services, Inc.$7K
  • Depuy Synthes Products, Inc.$4K
  • Zimmer Biomet$278
  • Medtronic$224
  • plus $539 from 6 others
$22,664in research payments, 2019–2025

Across 8 payments — averaging $2833.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Stryker$23K

What the payments were for

  • Consulting fees$21,54444%
  • Speaking & faculty fees$21,79445%
  • Travel & lodging$2,8366%
  • Food & beverage$2,5325%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$48,706 in reported general payments places this provider in the 75th percentile of 59 adult reconstructive orthopaedic surgery providers in Ohio.

See all adult reconstructive orthopaedic surgery providers in Ohio

Medicare billing

Part B allowed, 2024
$279,886
Medicare patients
449
Services billed
4,841

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban18$9,675
Diclofenac Sodium295$3,007
Sulindac216$2,614
Celecoxib16$1,174
Cefadroxil175$963
Gabapentin167$816
Meloxicam110$538
Methylprednisolone93$516
Methocarbamol121$458
Prednisone100$221
Oxycodone Hcl39$170
Amoxicillin95$154
Ondansetron OdtOndansetron12$149
Clindamycin Hcl28$70
Tramadol Hcl18$62

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Cincinnati

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →